Navigation Links
Pharmatek's Highly-Potent and Cytotoxic (HP/C) Facility Positions It as Industry Leader in Development and Manufacturing of HP/C Compounds
Date:5/5/2009

Pharmatek Demonstrates Effectiveness Of New Highly-Potent And Cytotoxic (HP/C) Facility Through Airborne Particulate Testing.

SAN DIEGO, May 5 /PRNewswire/ -- Pharmatek Laboratories, Inc. - a premier pharmaceutical chemistry development organization supporting the pharmaceutical industry - has completed comprehensive airborne particulate testing of its new state-of-the-art facility for the development and manufacturing of highly-potent and cytotoxic compounds.

"The testing results of our HP/C facility allows Pharmatek to expand our development and manufacturing services to include highly potent and cytotoxic compounds, and do it in the safest possible way," says Tim Scott, President of Pharmatek Laboratories. "The results from extensive facility testing exceeded Pharmatek's expectations for the safe handling of category 4 compounds on a 5 band scheme."

The monitoring results exceeded the testing goals and demonstrate Pharmatek's engineering controls and practices are effective at controlling airborne particulates down to 0.1ug/m3 levels.

"Combined with the facility engineering controls, significantly lower particulate levels are achieved when respiratory protection factors and process specific enclosure systems are taken into account. The specific operator breathing zone results, on an actual time-weighted basis, demonstrate that Pharmatek can safely handle highly-potent and cytotoxic compounds," says Kevin Rosenthal, Director of Manufacturing at Pharmatek Laboratories.

The facility was specifically designed for the development and manufacturing of HP/C drug products. The dedicated facility includes 18,000 sq. ft. of analytical, formulation development and manufacturing lab space. In addition to the development space, there are two certified and validated high-containment manufacturing suites designed with soft-wall enclosure systems that give flexibility to meet the demands of each client's project.

About Pharmatek Laboratories, Inc.

Pharmatek Laboratories Inc. is a pharmaceutical chemistry development company providing full-service pharmaceutical chemistry product development for the pharmaceutical industry. Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing, and stability storage and testing.

Statements contained in this media release which are not historical facts may constitute forward-looking statements. All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those projected including sales forecasts and strategic expansion. The trademarks Pharmatek, Pharmatek Laboratories, Inc., Hot Rod Chemistry and Pharmatek Formulation Screening are all property of Pharmatek Laboratories, Inc. Additional information about Pharmatek Laboratories may be obtained at the Web site http://www.pharmatek.com or by calling 858-805-6383.

    Company Contact:
    Ryan Lane, Marketing Coordinator
    Pharmatek Laboratories, Inc.
    (858) 805-6383 x284
    rlane@pharmatek.com

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Jeffrey A. Bibbs

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=48157

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Timothy M. Scott

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=50335


'/>"/>
SOURCE Pharmatek Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens
2. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
3. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
4. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
5. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
6. Isogen Launches Major New Facility to Address Global Biopharma Demand
7. Micromet Expands Committed Equity Financing Facility to $75 Million
8. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
9. U.S. Meat Industry Will Respond to World Cancer Research Fund Report
10. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
11. EntreMed to Present at The New York Society of Security Analysts Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 2017   Dynatronics Corporation (NASDAQ: ... Cynthia L. McHenry (Cyndi) as Vice ... leading Dynatronics manufacturing, distribution, and purchasing operations across ... CEO Kelvyn H. Cullimore, Jr. ... process conducted by the company as it continues ...
(Date:3/29/2017)... NetworkNewsWire Editorial Coverage  ... There are a number of advantages ... economic arguments also favor its legalization. The benefits include increased ... to legalize and regulate marijuana requires an ecosystem of support ... SING Profile ), American Cannabis Company (OTC: AMMJ), Kush Bottles, ...
(Date:3/29/2017)... AVIV, Israel , March 29, 2017 ... agreement in which Exeltis will obtain exclusive marketing rights for Neurim,s ... ... an age-appropriate drug targeted to treat sleep disorders in children with ... be the first sleep medication approved for children. The ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... ... 29, 2017 , ... Altima Technologies, Inc., the maker of ... center assets and audio-video devices has recently updated its Visio Stencils library with ... and download shapes and stencils from http://www.VisioStencils.com. , New devices were ...
(Date:3/29/2017)... Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... of a growing number of cancers and is touted to be the next revolution ... treatment, thus far, has been in the form of immune checkpoint inhibitors such as ...
(Date:3/29/2017)... ... , ... AvePoint , the Microsoft Cloud expert, is pleased to announce ... at the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ... and Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... first technology to directly address the resolution to globally reduce the harmful use ... patented compound of FDA and TTB approved ingredients that when infused into alcohol, ...
Breaking Medicine News(10 mins):